Our Work

This survey shows COVID-19 booster rates are higher in U.S. adults with diabetes than the general population, but vary by race, income, and location.

New dQ&A data tracks GLP-1 & SGLT2 trends, patient/HCP insights, satisfaction, and market shifts to guide diabetes drug decisions.

We are excited to announce dQ&A’s new syndicated qualitative research service, First Look Insights.